One of the world's leading healthcare companies, Novartis' dedication to scientific research, imagination, and new technologies has led to the creation of thousands of groundbreaking products and services in the areas of pharmaceuticals, nutrition, eye-care, and animal health.
 

That dedication is reflected in our name -- Novartis -- which is derived from the Latin, novae artes, signifying new skills. It reflects our drive to be on the leading edge of the healthcare industry, a visionary company with a "product pipeline" filled with remarkable breakthroughs.

Novartis was born in 1996 from the merger of the Swiss-based pharmaceutical companies, Ciba-Geigy and Sandoz. With a heritage stretching back over two centuries, Novartis today is a world leader with offices, research centres, and major research partnerships and alliances around the globe.

Our roots in Canada run deep. Ciba was established in Montreal in 1922 and J.R. Geigy in Toronto in 1945.  Sandoz also began its activities in Canada in the 1920s. Today, Novartis Pharmaceuticals Canada Inc. is a leading research-based company with a wide-ranging program for the development and marketing of innovative prescription medications in Canada. The Company's national head office building, completed in 2003, is located in Dorval, Quebec.

In the area of healthcare, Novartis is represented by: